ClinicalTrials.Veeva

Menu

French Study in Real Life Evaluating Xybilun (XY-FILM)

L

Laboratoires Genévrier

Status

Completed

Conditions

Erectile Dysfunction

Treatments

Drug: Xybilun

Study type

Observational

Funder types

Industry

Identifiers

NCT04114240
2017-A03204-49

Details and patient eligibility

About

Collecting Xybilun (Viagra's generic) efficacity, tolerance, convenience and patients/doctors satisfaction's data at different doses (50-75-100 mg), is the aim of the study.

Full description

Study design

Population Patients without prior treatment with a first Xybilun prescription Patients already treated for who the treatment is remplaced by Xybilun

Study perimeter 400 patients 50 investigators (sexologists, urologists)

Enrollment

105 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > or equal 18 years
  • Erectile dysfunction at V1 light (group 1), moderate (group 2), severe (group 3): IIEF-6 score between 6 and 25 (IIEF-6 questions 1-5 and question 15)
  • More than 3 sexual intercourse
  • First prescription of Xybilun (gr 1,2,3) or subtitution (gr 4)
  • Information and non-opposition

Exclusion criteria

  • Sildénafil hypersensitivity
  • Treatment with nitrogen oxide or guanylate cyclase
  • Patient with sexual intercourse prohibited
  • NOIANA
  • Alpha-blocker during past 3 months
  • Norvir
  • Participation in an other clinical trial
  • Patient unable to read properly an information sheet
  • Patient under guardianship/curatorship

Trial design

105 participants in 4 patient groups

Xybilun: mild erectil dysfunction
Description:
Patient who has never been treated for his ED (erectil dysfunction), with mild ED (score IIEF-6 between 22 and 25) and begin treatment at 50 mg
Treatment:
Drug: Xybilun
Xybilun: moderate erectil dysfunction
Description:
Patient who has never been treated for his ED (erectil dysfunction), with moderate ED (score IIEF-6 between 11 and 21) and begin treatment at 50 mg
Treatment:
Drug: Xybilun
Xybilun: severe erectil dysfunction
Description:
Patient who has never been treated for his ED (erectil dysfunction), with severe ED (score between 6 and 10) and begin treatment at 50 mg
Treatment:
Drug: Xybilun
Xybilun switch
Description:
Substitution dose to dose of previous treatment by Xybilun whatever the severity of ED.
Treatment:
Drug: Xybilun

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems